Posts Tagged: "IPWatchdog Webinars"

Webinar: Unprotected Trade Secrets – Identifying and Protecting Unrealized Confidential Assets

Many executives and attorneys do not understand trade secrets. Even C-suite executives at many tech companies often mistakenly believe they do not have any trade secrets worth protecting. If you have patents, you also have trade secrets worth protecting. And despite popular misconception, patents and trade secrets can, do, and absolutely should co-exist. On Thursday, November 16, 2023, at 1…

Webinar: Evidence Mining to Dominate in High-Tech Patent Litigation

Microchips control the behavior of all modern devices and are frequently the centerpiece of high-tech patent infringement litigation. However, these cases are complex, expensive, and prone to errors that can compromise the outcome of your case if not done right.  To dominate high-tech patent litigations, a well-conceived approach to optimizing your budget for compiling high-impact evidence can be the difference…

Webinar: Using AI to Transform and Unlock Your IP Landscape

In today’s rapidly evolving business landscape, intellectual property (IP) teams face unprecedented challenges. The need to protect and monetize patents, trademarks, and copyrights has never been more critical, yet budgets are decreasing. Using Artificial Intelligence (AI) to unlock business value with intelligent insights will be – and already is – a game-changer for those willing to thoughtfully leverage the tool…

Webinar: Recognizing The Importance of Global Standards

The system behind global standards, such as 5G, is one of the great commercial success stories of the modern industrial age. The process of collaboration, which brings together innovators from around the world, advances technologies and helps deliver ever-more sophisticated devices to consumers. Standardized technologies should be supported by balanced IP rights, but they unfortunately face an increasingly uncertain policy…

Webinar: Claiming Genus Solid-Form Patent Claims in the Post-Amgen v. Sanofi Era

Solid-form patents provide drug substance patent protection for many pharmaceutical small molecule programs. Many of the claims of such patents are drawn narrowly to cover the specific crystal form of the corresponding marketed drug product. However, solid form screens often reveal multiple solid forms of an API and, as with traditional chemical structure claims, the resulting data may warrant genus…